The Environmental Protection Agency (EPA) recently finalized a rule to strengthen transparency in the science underlying regulatory health and safety roles. This transparency refers to making data from epidemiological studies available for evaluation by independent observers, since the studies often serve as the foundation for regulations that address exposure to substances that can affect health. Yet some scientists think this Trump-era rule should be repealed. These critics worry that people’s confidential personal health data may be revealed and as a result, deter people from participating in future studies. But, beyond regulations, access to personal health data is essential for us to improve public health as we move toward precision medicine.
Read more in Real Clear Policy.